Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III, Randomized, Unblinded, Controlled Clinical Trial for Evaluating the Effectiveness of the Use of the New Hemostatic Patch Hemopatch ® in Patients Undergoing Surgical Liver Resection

NCT02769754 is registered in ClinicalTrials.gov with Instituto de Investigacion Sanitaria La Fe as lead sponsor.

NCT NCT02769754
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02769754 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III, Randomized, Unblinded, Controlled Clinical Trial for Evaluating the Effectiveness of the Use of the New Hemostatic Patch Hemopatch ® in Patients Undergoing Surgical Liver Resection
Lead sponsor
Instituto de Investigacion Sanitaria La Fe
Phase
Phase 3
Overall status
Unknown status
Start date
May 31, 2016
Completion date
May 31, 2019
Enrollment
250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver damage, surgery